# clm_ADD13B3620DD

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 5,531,300,000 United States dollar  
valid_from: 2013-12-31  
valid_to: 2014-12-31  
published: 2014-02-19  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_8C0CCBB2961E  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 5,531,300,000 United States dollar", as of 2013-12-31 (until 2014-12-31). Claim clm_ADD13B3620DD, https://asof.is/claim/clm_ADD13B3620DD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947814000078/0000059478-14-000078-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2013, filed 2014-02-19  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947814000078/0000059478-14-000078-index.htm (primary, SEC EDGAR 10-K FY2013, published 2014-02-19)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 5,278,100,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_ADD13B3620DD](/claim/clm_ADD13B3620DD.md) | [clm_1B4BD9A59709](/claim/clm_1B4BD9A59709.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.